Related Experiment Videos
Estimation of complement C3 in oral submucous fibrosis
1Mahatma Gandhi Institute of Medical Sciences, Sevagram, India.
International Journal of Oral and Maxillofacial Surgery
|December 1, 1987
Summary
Serum C3 levels were investigated in oral submucous fibrosis patients due to immunological findings. This chronic oral disease showed unaltered serum C3 complement levels, suggesting no significant complement system involvement.
Area of Science:
- Immunology
- Oral Pathology
- Biochemistry
Background:
- Oral submucous fibrosis (OSF) is a chronic, potentially malignant oral disorder with an unclear cause.
- Immunological factors are implicated in the pathogenesis of OSF.
- The role of the complement system, specifically C3, in OSF requires further elucidation.
Purpose of the Study:
- To investigate the serum C3 complement levels in patients diagnosed with oral submucous fibrosis.
- To assess the potential involvement of the complement system in the immunological response associated with OSF.
Main Methods:
- Serum samples were collected from patients with oral submucous fibrosis.
- Serum C3 levels were quantified using the radial immunodiffusion (RID) method.
Main Results:
- Serum C3 levels in patients with oral submucous fibrosis were found to be unaltered when compared to control groups (implied).
- The results indicate no significant deviation in the concentration of the C3 complement component in the studied OSF cohort.
Conclusions:
- The study suggests that serum C3 levels are not significantly altered in oral submucous fibrosis.
- These findings imply that the classical complement pathway, as reflected by C3 levels, may not play a major role in the pathogenesis or immunological profile of OSF.